Superior Therapeutic Efficacy of a Novel Oral Small Molecule Retinoic Acid Receptor-Related Orphan Receptor Gamma T [Rorgt] Inverse Agonist Inv-17: A Promising Safe & Efficacious Treatment for Rheumatoid Arthritis

被引:0
|
作者
Gaweco, Anderson [1 ]
Palmer, Samantha [1 ]
Shamilov, Rambon [1 ]
Stremnitzer, Caroline [1 ]
Matthews, Katie [1 ]
Fisher, Michael [1 ]
Windsor, William [1 ]
Blinn, James [1 ]
Ginzler, Ellen M. [2 ]
Tilley, Jefferson [1 ]
机构
[1] Innovimmune Biotherapeut, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
322
引用
收藏
页码:S137 / S137
页数:1
相关论文
共 11 条
  • [1] COMPLETE SURVIVAL AND DISEASE AMELIORATION IN MRL/LPR MICE FOLLOWING THERAPEUTIC ADMINISTRATION OF AN ORAL RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR GAMMA T [RORGT] INVERSE AGONIST INV-17: A PROMISING SAFE & EFFICACIOUS NOVEL LUPUS TREATMENT
    Gaweco, A.
    Matthews, K.
    Palmer, S.
    Shamilov, R.
    Adam, K.
    Elia, A.
    Clybouw, C.
    Windsor, W.
    Nomeir, A.
    Stouch, T.
    Ginzler, E.
    Tilley, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 120 - 120
  • [2] Therapeutic Efficacy of a Novel Oral Small Molecule Macrophage Migration Inhibitory Factor [MIF] Inhibitor: A Promising Safe & Efficacious Treatment for Rheumatoid Arthritis.
    Gaweco, Anderson
    Palmer, Samantha
    Shamilov, Rambon
    Stremnitzer, Caroline
    Fisher, Michael
    Crichlow, Gregg
    Windsor, William
    Ginzler, Ellen M.
    Tilley, Jefferson
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S665 - S665
  • [3] Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
    Chen, Lei
    Su, Mei
    Jin, Qiu
    Wang, Wei
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Liao, Zhi-Xin
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 16106 - 16131
  • [4] Discovery of Novel N-Sulfonamide-tetrahydroquinolines as Potent Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists for the Treatment of Psoriasis
    Lv, Lunan
    Chen, Baiyu
    Gao, Yang
    Sun, Nannan
    Li, Wei
    Fu, Wei
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21400 - 21420
  • [5] Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases
    Sun, Nannan
    Ma, Xiaojun
    Zhou, Kaifeng
    Zhu, Chen
    Cao, Zhonglian
    Wang, Yonghui
    Xu, Jun
    Fu, Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [6] Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist (vol 64, pg 16106, 2021)
    Chen, Lei
    Su, Mei
    Wang, Wei
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Jin, Qiu
    Liao, Zhi-Xin
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 18235 - 18235
  • [7] Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist (vol 64, pg 16106, 2021)
    Chen, Lei
    Su, Mei
    Wang, Wei
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Jin, Qiu
    Liao, Zhi-Xin
    JOURNAL OF MEDICINAL CHEMISTRY, 2021,
  • [8] Safety, Tolerability, and Pharmacokinetics of IMU-935, a Novel Inverse Agonist of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γt: Results From a Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study
    Polasek, Thomas M.
    Leelasena, Indika
    Betscheider, Irina
    Marolt, Marija
    Kohlhof, Hella
    Vitt, Daniel
    Fliegert, Frank
    Muehler, Andreas R.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 525 - 534
  • [9] Discovery of N-(2-benzyl-4-oxochroman-7-yl)-2-(5-(ethylsulfonyl) pyridin-2-yl) acetamide (b12) as a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist
    Chen, Lei
    Su, Mei
    Jin, Qiu
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Liao, Zhi-Xin
    BIOORGANIC CHEMISTRY, 2022, 119
  • [10] The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse Agonist
    Kumar, Naresh
    Solt, Laura A.
    Conkright, Juliana J.
    Wang, Yongjun
    Istrate, Monica A.
    Busby, Scott A.
    Garcia-Ordonez, Ruben D.
    Burris, Thomas P.
    Griffin, Patrick R.
    MOLECULAR PHARMACOLOGY, 2010, 77 (02) : 228 - 236